Page last updated: 2024-08-21

aminoimidazole carboxamide and Ventricular Dysfunction, Left

aminoimidazole carboxamide has been researched along with Ventricular Dysfunction, Left in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benham, A; Entman, ML; Kaelber, JT; Kim, E; Nam, DH; Park, HK; Reineke, EL; Soibam, B; Suh, JH; Taegtmeyer, H; Taffet, GE1
Ambrosio, G; Clare, RM; Ferguson, TB; Fremes, S; Harrington, RA; Lira, A; Menasché, P; Mongero, L; Newman, MF; Nussmeier, N; Pearl, RG; Pieper, KS; Pitt, B; Reece, TL; Wechsler, AS; Weisel, RD; Yau, TM1
Asakura, M; Asanuma, H; Fujita, M; Ito, S; Kim, J; Kitakaze, M; Komamura, K; Minamino, T; Mochizuki, N; Ogai, A; Sanada, S; Sasaki, H; Sugimachi, M; Takahama, H; Takashima, S; Wakeno, M1
Ambrosio, G; Ferguson, TB; Harrington, RA; Koglin, J; Lira, A; Newman, MF; Nussmeier, NA; Pearl, RG; Pitt, B; Reece, TL; Wechsler, AS; Weisel, RD; White, JA1
Hill, GE1

Reviews

1 review(s) available for aminoimidazole carboxamide and Ventricular Dysfunction, Left

ArticleYear
Cardiopulmonary bypass-induced inflammation: is it important?
    Journal of cardiothoracic and vascular anesthesia, 1998, Volume: 12, Issue:2 Suppl 1

    Topics: Aminoimidazole Carboxamide; Anti-Inflammatory Agents; Cardiopulmonary Bypass; Cell Adhesion; Child; Cytokines; Down-Regulation; Endothelium, Vascular; Endotoxins; Hemofiltration; Humans; Inflammation Mediators; Intercellular Adhesion Molecule-1; Interleukin-1; Interleukin-6; Macrophage-1 Antigen; Myocardial Ischemia; Myocardial Reperfusion Injury; Neutrophils; Nitric Oxide; Nitric Oxide Synthase; Platelet Activation; Ribonucleosides; Serine Proteinase Inhibitors; Systemic Inflammatory Response Syndrome; Tumor Necrosis Factor-alpha; Up-Regulation; Ventricular Dysfunction, Left

1998

Trials

2 trial(s) available for aminoimidazole carboxamide and Ventricular Dysfunction, Left

ArticleYear
Predictors of contemporary coronary artery bypass grafting outcomes.
    The Journal of thoracic and cardiovascular surgery, 2014, Volume: 148, Issue:6

    Topics: Age Factors; Aminoimidazole Carboxamide; Aspirin; Cardiopulmonary Bypass; Cardiovascular Agents; Chi-Square Distribution; Coronary Artery Bypass; Double-Blind Method; Heart Failure; Humans; Logistic Models; Multivariate Analysis; Odds Ratio; Patient Selection; Peripheral Arterial Disease; Protective Factors; Ribonucleosides; Risk Assessment; Risk Factors; Stroke; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left

2014
Effect of adenosine-regulating agent acadesine on morbidity and mortality associated with coronary artery bypass grafting: the RED-CABG randomized controlled trial.
    JAMA, 2012, Jul-11, Volume: 308, Issue:2

    Topics: Adenosine; Aged; Aminoimidazole Carboxamide; Coronary Artery Bypass; Coronary Artery Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Perioperative Period; Reperfusion Injury; Ribonucleosides; Stroke; Ventricular Dysfunction, Left

2012

Other Studies

2 other study(ies) available for aminoimidazole carboxamide and Ventricular Dysfunction, Left

ArticleYear
Transient activation of AMPK preceding left ventricular pressure overload reduces adverse remodeling and preserves left ventricular function.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2019, Volume: 33, Issue:1

    Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Cardiomegaly; Hypoglycemic Agents; Male; Mice; Mice, Knockout; Myocytes, Cardiac; Nuclear Receptor Coactivator 2; Ribonucleotides; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Pressure; Ventricular Remodeling

2019
Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase.
    Circulation, 2009, May-19, Volume: 119, Issue:19

    Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Apoptosis; Cardiotonic Agents; Cells, Cultured; Disease Progression; Dogs; Drug Evaluation, Preclinical; Fibrosis; Gene Expression Regulation; Heart Failure; Insulin Resistance; Metformin; Myocytes, Cardiac; Natriuretic Peptides; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphorylation; Protein Processing, Post-Translational; Pyrazoles; Pyrimidines; Rats; Rats, Wistar; Ribonucleotides; Transforming Growth Factor beta1; Ultrasonography; Ventricular Dysfunction, Left

2009